Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Analysts are expecting strong performance who makes tirzepatides for Eli Lilly driven by the robust sales of Lilly's blockbuster treatments, particula